Exercise Induced Bronchospasm in Children

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to test how well 2 different medications stop asthma symptoms caused by exercising. The two medications that will be tested are "pretreatment with albuterol" and montelukast (Singulair®). Although both medications are used for treating asthma, we don't know which medicine is better at stopping asthma symptoms caused by exercising.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of New Mexico
• Collaborator: American College of Clinical Pharmacy
• Treatments: Albuterol; Montelukast

Criteria

Inclusion Criteria:

• Children 7-17 years of age

• Physician diagnosed asthma for at least 6 months

• EIB diagnosed by a positive exercise challenge at screening and baseline visits

• Forced expiratory volume in 1 second (FEV1) ≥ 70% of predicted at screening and baseline visit

Exclusion Criteria:

• History of cardiac dysfunction

• Unable to perform exercise challenge

• Use of montelukast